Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 26, Issue 1, 2015, Pages 21-27

  Navaravong, Leenhapong ^a   Barakat, Michel ^a   Burgon, Nathan ^a   Mahnkopf, Christian ^a   Koopmann, Matthias ^a   Ranjan, Ravi ^a   Kholmovski, Eugene ^a   Marrouche, Nassir ^a   Akoum, Nazem ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

atrial fibrillation; atrial fibrosis; cardiac MRI; catheter ablation; chronic kidney disease

Indexed keywords

CREATININE; GADOLINIUM; BIOLOGICAL MARKER; CONTRAST MEDIUM; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; ARTICLE; ATRIAL FIBROSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CHRONIC KIDNEY DISEASE; CONTRAST ENHANCEMENT; CREATININE BLOOD LEVEL; FEMALE; FIBROSIS; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; AGED; ANALOGS AND DERIVATIVES; ATRIAL FIBRILLATION; BLOOD; COMPLICATION; CONVALESCENCE; DIAGNOSTIC USE; FACTUAL DATABASE; HEART ATRIUM; KIDNEY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; TIME; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CATHETER ABLATION; CONTRAST MEDIA; CREATININE; DATABASES, FACTUAL; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HEART ATRIA; HUMANS; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RECURRENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UTAH;

EID: 84921502571     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12530     Document Type: Article

References (35)

1. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH,: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16: 180-188.
2. European Heart Rhythm Association, European Association for Cardiothoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH,: ESC Committee for Practice Guidelines Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-1420.
3. Herzog CA, Asinger RW, Berger AK, Charytan DM, Diez J, Hart RG, Eckardt KU, Kasiske BL, McCullough PA, Passman RS, DeLoach SS, Pun PH, Ritz E,: Cardiovascular disease in chronic kidney disease: A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2011; 80: 572-586.
4. Baber U, Howard VJ, Halperin JL, Soliman EZ, Zhang X, McClellan W, Warnock DG, Muntner P,: Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ Arrhythm Electrophysiol 2011; 4: 26-32.
5. U.S. Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2012.
6. Allessie M, Ausma J, Schotten U,: Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovascular Research 2002; 54: 230-236.
7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
8. NKF, K/DOQI Clinical Practice Guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-S266.
9. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, Fish EN, Blauer JJ, Rao SN, DiBella EV, Segerson NM, Daccarett M, Windfelder J, McGann CJ, Parker D, MacLeod RS, Marrouche NF,: Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009; 119: 1758-1767.
10. Akoum N, Daccarett M, McGann C, Segerson N, Vergara G, Kuppahally S, Badger T, Burgon N, Haslam T, Kholmovski E, Macleod R, Marrouche N,: Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: A DE-MRIguided approach. J Cardiovasc Electrophysiol 2011; 22: 16-22.
11. Segerson N, Daccarett M, Badger T, Shabaan A, Akoum N, Fish E, Rao S, Burgon N, Adjei-Poku Y, Kholmovski E, Vijayakumar S, Dibella E, MacLeod R, Marrouche N,: Magnetic resonance imaging-confirmed ablative debulking of the left atrial posterior wall and septum for treatment of persistent atrial fibrillation: Rationale and initial experience. J Cardiovasc Electrophysio 2009; 21: 126-132.
12. Ehrlich JR, Hohnloser SH, Nattel S,: Role of angiotensin system and effects of its inhibition in atrial fibrillation: Clinical and experimental evidence. Eur Heart J 2006; 27: 512-518.
13. Shi Y, Li D, Tardif JC, Nattel S,: Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 2002; 54: 456-461.
14. Sakabe M, Fujiki A, Nishida K, Sugao M, Nagasawa H, Tsuneda T, Mizumaki K, Inoue H,: Enalapril prevents perpetuation of atrial fibrillation by suppressing atrial fibrosis and over-expression of connexin43 in a canine model of atrial pacing-induced left ventricular dysfunction. J Cardiovasc Pharmacol 2004; 43: 851-859.
15. Li Y, Li W, Yang B, Han W, Dong D, Xue J, Li B, Yang S, Sheng L,: Effects of cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs. J Electrocardiol 2007; 40:100. e1-e6.
16. Boldt A, Scholl A, Garbade J, Resetar ME, Mohr FW, Gummert JF, Dhein S,: ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation. Basic Res Cardiol 2006 101: 261-267.
17. Williams RS, deLemos JA, Dimas V, Reisch J, Hill JA, Naseem RH,: Effect of spironolactone on patients with atrial fibrillation and structural heart disease. Clin Cardiol 2011; 34: 415-419.
18. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, Metelli MR, Giovannini L, Tetta C, Palla R,: C reactive protein in patients with chronic renal diseases. Ren Fail 2001; 23: 551-562.
19. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM,: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92.
20. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, Tracy RP, Van Wagoner DR, Psaty BM, Lauer MS, Chung MK,: Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-3010.
21. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, Wildevuur CR, Eijsman L, Trouwborst A, Hack CE,: Activation of the complement system during and after cardiopulmonary bypass surgery: Postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96: 3542-3548.
22. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR,: C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891.
23. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A,: Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-1184.
24. Gaudino M, Andreotti F, Zamparelli R, Di Castelnuovo A, Nasso G, Burzotta F, Iacoviello L, Donati MB, Schiavello R, Maseri A, Possati G,: The Ï174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation: Is atrial fibrillation an inflammatory complication? Circulation 2003; 108 (Suppl 1): II-195-II-199.
25. Gedikli O, Dogan A, Altuntas I, Altinbas A, Ozaydin M, Akturk O, Acar G,: Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 2007; 120: 193-197.
26. Kumagai K, Nakashima H, Saku K,: The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. Cardiovasc Res 2004; 62: 105-111.
27. Shiroshita-Takeshita A, Brundrel B, Burstein B, Leung T, Mitamura H, Ogawa S, Nattel S: Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure. Cardiovasc Res 2007; 74: 75-84.
28. Yagi S, Akaike M, Aihara K, Ishikawa K, Iwase T, Ikeda Y, Soeki T, Yoshida S, Sumitomo-Ueda Y, Matsumoto T, Sata M,: Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury. Hypertension 2010; 55: 918-923.
29. Fauchier L, Clementy N, Babuty D,: Statin therapy and atrial fibrillation: Systematic review and updated meta-analysis of published randomized controlled trials. Curr Opin Cardiol 2013; 28: 7-18.
30. Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, Yamasaki H, Igarashi M, Kuroki K, Itoh Y, Murakoshi N, Yamaguchi I, Aonuma K,: Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: A mid-term follow-up. Heart Rhythm 2011; 8: 335-341.
31. Providência R, Fernandes A, Paiva L, Faustino A, Barra S, Botelho A, Trigo J, Nascimento J, Leitão-Marques A: Decreased glomerular filtration rate and markers of left atrial stasis in patients with nonvalvular atrial fibrillation. Cardiology 2013; 124: 3-10.
32. Muellerleile K, Groth M, Steven D, Hoffmann BA, Saring D, Radunski UK, Lund GK, Adam G, Rostock T, Willems S,: Cardiovascular magnetic resonance demonstrates reversible atrial dysfunction after catheter ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2013; 24: 762-767.
33. Machino-Ohtsuka T, Seo Y, Ishizu T, Yanaka S, Nakajima H, Atsumi A, Yamamoto M, Kawamura R, Koshino Y, Machino T, Kuroki K, Yamasaki H, Igarashi M, Sekiguchi Y, Tada H, Aonuma K,: Significant improvement of left atrial and left atrial appendage function after catheter ablation for persistent atrial fibrillation. Circ J 2013; 77: 1695-1704.
34. La Meir M, Gelsomino S, Lucà F, Pison L, Rao CM, Wellens F, Maessen JG,: Improvement of left atrial function and left atrial reverse remodeling after minimally invasive radiofrequency ablation evaluated by two-dimensional speckle tracking echocardiography. J Thorac Cardiovasc Surg 2013; 146: 72-77.
35. Takahashi Y, Takahashi A, Kuwahara T, Okubo K, Fujino T, Takagi K, Nakashima E, Kamiishi T, Hikita H, Hirao K, Isobe M,: Renal function after catheter ablation of atrial fibrillation. Circulation 2011; 124: 2380-2387.